Market Tracker

03/06 8:52am ET

Synageva BioPharma Corp (NASDAQ:GEVA)

Thursday’s Trading Day
101.24 -1.05 / -1.03%
As of Mar 05
Day’s Change
Friday’s Pre-Market   Switch to standard view »
101.28 +0.04 / +0.04%
 
Volume: 100.00
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close102.29
Today’s open102.99
Day’s range-- - --
Volume343,233
Average volume (3 months)317,425
Market cap$3.8B
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-27.52%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.02-0.07%
BLUEbluebird bio Inc+12.18+12.17%
JUNOJuno Therapeutics In...+2.03+4.06%
KITEKite Pharma Inc+1.78+2.82%
Data as of 03/05/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts